Search research articles
Contact Us
Filters
Showing results (41-50 of 69) with videos related to
Page
of 7
Sort By:
American Journal of Cancer Research
|
January 10, 2018
Low <i>SLC29A1</i> expression is associated with poor prognosis in patients with hepatocellular carcinoma
Ping-Ting Gao, Jian-Wen Cheng, Zi-Jun Gong, et al.
Cell Death & Disease
|
July 26, 2020
Anlotinib suppresses tumor progression via blocking the VEGFR2/PI3K/AKT cascade in intrahepatic cholangiocarcinoma
Fei Song, Bo Hu, Jian-Wen Cheng, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
May 3, 2025
Postoperative circulating tumor cells predict the benefits of tyrosine kinase inhibitor for hepatocellular carcinoma after transplantation
De-Zhen Guo, Shi-Yu Zhang, Man Yang, et al.
Annals of Translational Medicine
|
November 17, 2022
Efficacy and safety of lenvatinib for preventing tumor recurrence after liver transplantation in hepatocellular carcinoma beyond the Milan criteria
De-Zhen Guo, Jian-Wen Cheng, Jia-Yan Yan, et al.
The Oncologist
|
March 27, 2019
Clinical Characteristics and Prognostic Factors of Patients with Intrahepatic Cholangiocarcinoma with Fever: A Propensity Score Matching Analysis
Zi-Jun Gong, Jian-Wen Cheng, Pin-Ting Gao, et al.
Journal of Cellular and Molecular Medicine
|
February 16, 2022
Hsa_circ_0003945 promotes progression of hepatocellular carcinoma by mediating miR-34c-5p/LGR4/β-catenin axis activity
Li-Hua Lyu, Chun-Yan Zhang, Wen-Jing Yang, et al.
Clinical and Translational Medicine
|
February 26, 2021
Arsenic trioxide induces differentiation of cancer stem cells in hepatocellular carcinoma through inhibition of LIF/JAK1/STAT3 and NF-kB signaling pathways synergistically
Xin Zhang, Bo Hu, Yun-Fan Sun, et al.
Frontiers in Oncology
|
July 30, 2021
Patient-Derived Xenograft Models for Intrahepatic Cholangiocarcinoma and Their Application in Guiding Personalized Medicine
Yang Gao, Rong Zhou, Jun-Feng Huang, et al.
ACS Applied Materials & Interfaces
|
August 2, 2022
Uncovering the Heterogeneity and Clinical Relevance of Circulating Tumor-Initiating Cells in Hepatocellular Carcinoma Using an Integrated Immunomagnetic-Microfluidic Platform
Wen-Jing Zheng, Peng-Xiang Wang, Yun-Fan Sun, et al.
Annals of Translational Medicine
|
July 16, 2021
A novel preoperative predictive model of 90-day mortality after liver resection for huge hepatocellular carcinoma
Yue Yin, Jian-Wen Cheng, Fei-Yu Chen, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 69) with videos related to
Sort By:
Page
of 7
American Journal of Cancer Research
|
January 10, 2018
Low <i>SLC29A1</i> expression is associated with poor prognosis in patients with hepatocellular carcinoma
Ping-Ting Gao, Jian-Wen Cheng, Zi-Jun Gong, et al.
Cell Death & Disease
|
July 26, 2020
Anlotinib suppresses tumor progression via blocking the VEGFR2/PI3K/AKT cascade in intrahepatic cholangiocarcinoma
Fei Song, Bo Hu, Jian-Wen Cheng, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
May 3, 2025
Postoperative circulating tumor cells predict the benefits of tyrosine kinase inhibitor for hepatocellular carcinoma after transplantation
De-Zhen Guo, Shi-Yu Zhang, Man Yang, et al.
Annals of Translational Medicine
|
November 17, 2022
Efficacy and safety of lenvatinib for preventing tumor recurrence after liver transplantation in hepatocellular carcinoma beyond the Milan criteria
De-Zhen Guo, Jian-Wen Cheng, Jia-Yan Yan, et al.
The Oncologist
|
March 27, 2019
Clinical Characteristics and Prognostic Factors of Patients with Intrahepatic Cholangiocarcinoma with Fever: A Propensity Score Matching Analysis
Zi-Jun Gong, Jian-Wen Cheng, Pin-Ting Gao, et al.
Journal of Cellular and Molecular Medicine
|
February 16, 2022
Hsa_circ_0003945 promotes progression of hepatocellular carcinoma by mediating miR-34c-5p/LGR4/β-catenin axis activity
Li-Hua Lyu, Chun-Yan Zhang, Wen-Jing Yang, et al.
Clinical and Translational Medicine
|
February 26, 2021
Arsenic trioxide induces differentiation of cancer stem cells in hepatocellular carcinoma through inhibition of LIF/JAK1/STAT3 and NF-kB signaling pathways synergistically
Xin Zhang, Bo Hu, Yun-Fan Sun, et al.
Frontiers in Oncology
|
July 30, 2021
Patient-Derived Xenograft Models for Intrahepatic Cholangiocarcinoma and Their Application in Guiding Personalized Medicine
Yang Gao, Rong Zhou, Jun-Feng Huang, et al.
ACS Applied Materials & Interfaces
|
August 2, 2022
Uncovering the Heterogeneity and Clinical Relevance of Circulating Tumor-Initiating Cells in Hepatocellular Carcinoma Using an Integrated Immunomagnetic-Microfluidic Platform
Wen-Jing Zheng, Peng-Xiang Wang, Yun-Fan Sun, et al.
Annals of Translational Medicine
|
July 16, 2021
A novel preoperative predictive model of 90-day mortality after liver resection for huge hepatocellular carcinoma
Yue Yin, Jian-Wen Cheng, Fei-Yu Chen, et al.
Page
of 7